BeiGene Stock (NASDAQ: BGNE) stock price, news, charts, stock research, profile.
You can purchase shares of BeiGene (NASDAQ:BGNE) through any online brokerage.
Other companies in BeiGene’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
BeiGene has a consensus price target of $265.39.
The stock price for BeiGene (NASDAQ: BGNE) is $194.655 last updated November 21, 2024 at 1:14 PM EST.
There are no upcoming dividends for BeiGene.
BeiGene’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for BeiGene.
BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.